Registered entities
Ubic Therapeutics Co., Ltd.
Reg. No. 165-81-01095South Korea
Investor mix
11 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 36% |
| Private equity | 3 | 27% |
| Other / undisclosed | 4 | 36% |
Developer of anti-cancer drugs based on Proteolysis Targeting Chimera
11 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 36% |
| Private equity | 3 | 27% |
| Other / undisclosed | 4 | 36% |